OSHKOSH CORP (OSK)
Oshkosh Corporation Reports 2026 First Quarter Results
Bristol-Myers Squibb Company (BMY)
Bristol Myers Squibb - Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in Adults
Bristol-Myers Squibb Co. (BMYMP)
Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in Adults
BRISTOL MYERS SQUIBB CO (BMY)
Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in Adults
Bristol-Myers Squibb Company (BMY)
Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in Adults
DOLLAR GENERAL CORP (DG)
Dollar General Literacy Foundation Celebrates Another One-Day Grant Milestone
ARTIVA BIOTHERAPEUTICS, INC. (ARTV)
Artiva Biotherapeutics Announces Pricing of $300 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
EMBRAER S.A. (EMBJ)
EMBRAER EARNINGS RELEASE 1Q26
ANI PHARMACEUTICALS INC (ANIP)
ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance
CASTELLUM, INC. (CTM)
Castellum Announces First Quarter 2026 Financial Results